Active not recruiting

A Study of LY2951742 in the Prevention of Chronic Migraine (REGAIN)

I5Q-MC-CGAI - ClinicalTrials.gov - NCT02614261

The main purpose of this study is to evaluate the efficacy of the study drug known as LY2951742 in participants with chronic migraine
How long will I be in the trial?
Your participation could last up to 18 months and include 18 visits to the study center
Email
Active not recruiting

A Study of LY2951742 in the Prevention of Chronic Migraine (REGAIN)

I5Q-MC-CGAI - ClinicalTrials.gov - NCT02614261

The main purpose of this study is to evaluate the efficacy of the study drug known as LY2951742 in participants with chronic migraine
How long will I be in the trial?
Your participation could last up to 18 months and include 18 visits to the study center
Email

Key Requirements

Age :

18-65

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-65

Sex

All

Participants must

Participant must have a diagnosis of chronic migraines, with a history of migraine headaches at least 1 year prior to screening for the study

Participant's migraines must have begun prior to age 50

Participants must NOT

Participant must not have a history of persistent daily headache, cluster headache or migraine subtypes including hemiplegic (sporadic or familial) migraine, ophthalmoplegic migraine, and migraine with brainstem aura (basilar-type migraine)

Trial Summary

Conditions the trial is for

Migraine

What the trial is testing?

LY2951742, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

825

Trial Dates

November 2015 - May 2021

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-65

Sex

All

Participants must

Participant must have a diagnosis of chronic migraines, with a history of migraine headaches at least 1 year prior to screening for the study

Participant's migraines must have begun prior to age 50

Participants must NOT

Participant must not have a history of persistent daily headache, cluster headache or migraine subtypes including hemiplegic (sporadic or familial) migraine, ophthalmoplegic migraine, and migraine with brainstem aura (basilar-type migraine)

Trial Summary

Conditions the trial is for

Migraine

What the trial is testing?

LY2951742, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

825

Trial Dates

November 2015 - May 2021

Trial Phase

3

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Migraine Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?